Endometriosis treatment sales will expand through 2036, with oral contraceptives at 46% within the drug type segment in 2026. The market is estimated at USD 3.9 billion in 2026, is projected to reach USD 6.6 billion by 2036 and is forecast to register a 5.4% CAGR between 2026 and 2036.